Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2024-04-28 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2023 Annual General Meeting (AGM) resolution announcement for Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, and voting results for various proposals including approval of the 2023 annual report, board and supervisory reports, profit distribution plan, financial reports, and appointment of accounting firms. The document also references that the full reports are disclosed elsewhere (on the Beijing Stock Exchange information platform) and does not contain the full reports themselves. The document is about the resolutions passed at the AGM and the voting outcomes, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4767 characters, which is consistent with a detailed voting results announcement rather than the full annual report or other reports. Therefore, the correct classification is DVA with high confidence.
2024-04-28 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details an investor relations event categorized as a "业绩说明会" (performance explanation meeting), held on April 26, 2024, where company management discussed the 2023 annual operating performance and answered investor questions. The content includes detailed Q&A about the company's 2023 financial performance, business strategy, and future plans. This matches the characteristics of a Call Transcript (CT), as it is a full text record of a company event focused on financial results and investor interaction, not just a brief announcement or summary. The document length is 1774 characters, which is short but contains substantive Q&A content, consistent with a transcript of an earnings or performance call rather than a simple announcement or report publication notice. Therefore, the best classification is Call Transcript (CT).
2024-04-28 Chinese
北京德恒（杭州）律师事务所关于江西新赣江药业股份有限公司2023年年度股东大会的法律意见书
Regulatory Filings
2024-04-28 Chinese
第二届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the meeting date, attendance, and the approval of the company's 2024 first quarter report. However, the actual quarterly report is not included here; instead, it references that the full 2024 first quarter report is disclosed separately on the Beijing Stock Exchange information disclosure platform. The document is short (757 characters) and serves as an announcement of the meeting resolution and approval of the quarterly report, not the report itself. According to the 'Menu vs Meal' rule, this is a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR).
2024-04-25 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period January to March 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the quarter. It is unaudited but contains substantive financial data and management commentary on financial results and business conditions. This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2024
2024-04-25 Chinese
第二届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 30th meeting of the company's second board of directors. It includes details about the meeting's time, place, attendance, and the approval of the 2024 first quarter report. However, the actual quarterly report is referenced as being disclosed separately on the Beijing Stock Exchange information platform (announcement number 2024-043). This document itself does not contain the financial statements or substantive financial data of the quarterly report but is rather a board meeting resolution announcement regarding the report. Therefore, it is not the quarterly report itself (IR) but an announcement related to board/management decisions. The best fitting category is Board/Management Information (MANG).
2024-04-25 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.